Sign up for our monthly email digest here.
September 2019 Newsletter
Last month we featured John James and his recently published research article, "Informed consent, shared-decision making and a reasonable patient’s wishes based on a cross-sectional, national survey in the USA using a hypothetical scenario," published in the BMJ. This month we want to show how this research can be applied in practical ways for advocacy and patient care.
You can also read more about John's advocacy work in this issue of our newsletter.

Summer is ending, but our advocacy work continues.
This issue we'd like to honor Jamee Cook, a wife and mom from Texas. She worked as a paramedic in the state of Texas for 11 years but now spends most of her time volunteering as a patient advocate. Read more about her advocacy for women who received breast implants in the August newsletter.
Here's a summary of our recent activities, a salute to a valiant patient safety activist, and more information on what we're doing to insure that medical treatments involving drugs or devices are safe, effective, and affordable.
This summer, we'd like to give a salute to a valiant patient safety activist, and more information on medical devices. The spotlight is on a Linda Radach, a true warrior in many areas, but particularly on medical device safety.
Spring 2018 Newsletter
Here's a summary of our spring events, a salute to a valiant patient safety activist, and more information on the Right to Try Act. The spotlight is on a warrior with Breast Implant-Associated Ana-Plastic Large Cell Lymphoma (BIA-ALCL) who turned to advocacy after realizing untold risks of her breast implants.

June 2017 Newsletter
Get the real story about the Right to Try Act and read our comments to FDA about its most recent activity. The spotlight is on one inspiring USA Patient Network member who uses a unique approach to help patients share their stories and advocate for safer, more effective treatments.
November 2016 Newsletter
Read about recent Patient Training Workshop, as well as upcoming opportunities to participate in FDA Advisory Committee Meetings for medical products and devices, 21st Century Cures Act, and NCHR's president Diana Zuckerman talk about biosimilars. Be sure to read our Network Member Spotlight!